NCT07138209
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- National Clinical Research Center for Blood Diseases Tianjin, Tianjin Municipality, China
Clinical trial condition
Recurrence
Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.
2,308 public trials
520 recruiting studies
Recurrence trial results
Recruiting
xDRIVE for Florida-based Cancer Patients
NCT07167381
- Conditions
- Cancer, Disease Attributes, Hematologic Diseases, +17 more
- Locations
-
- First Ascent Biomedical Miami, Florida, United States
- Florida International University Miami, Florida, United States
NCT05685173
- Conditions
- B-cell Non-Hodgkins Lymphoma (B-NHL), Disease Attributes, Pathologic Processes, +2 more
- Locations
-
- City of Hope Duarte, California, United States
- University of California Los Angeles (UCLA) Medical Center Santa Monica, California, United States
- Norton Cancer Institute Louisville, Kentucky, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT06305299
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +24 more
- Locations
-
- Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
NCT01790152
- Conditions
- Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +24 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
- Arkansas Children's Hospital Little Rock, Arkansas, United States
NCT06949423
- Conditions
- Alcohol Use Disorder (AUD), Alcohol-Related Disorders, Alcoholism, +8 more
- Locations
-
- VA Palo Alto Health Care System Palo Alto, California, United States
Recruiting
Association Between Irrigation Fluid Absorption and Perioperative cfDNA Dynamics After TURBT
NCT07589413
- Conditions
- Bladder (Urothelial, Transitional Cell) Cancer, Bladder Cancer Recurrence, Carcinoma, +22 more
- Locations
-
- The Second Hospital of Lanzhou University Lanzhou, Gansu, China
Recruiting
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
NCT07342478
- Conditions
- CLL, CLL (Chronic Lymphocytic Leukemia), CLL / SLL, +23 more
- Locations
-
- The Center for Cancer and Blood Disorders-Bethesda Bethesda, Maryland, United States
- Optum Medical Group (Rhodes) P.C. Las Vegas, Nevada, United States
- OSU Comprehensive Cancer Center Columbus, Ohio, United States
- UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
NCT07002112
- Conditions
- Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
- Locations
-
- The First Affiliated Hospital of USTC west district Hefei, Anhui, China
- Beijing Gobroad Boren Hospita Beijing, Beijing Municipality, China
- The Fourth Hospital of Hebei Medical University Shijiazhuang, Hebei, China
- The First Affiliated Hospital of ZHENGZHOU University Zhengzhou, Henan, China
NCT07584499
- Conditions
- Atypical Teratoid/Rhabdoid Tumors, Carcinoma, Carcinoma, Squamous Cell, +53 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China